
Preclinical testing at The Ohio State University found Telomir-Zn inhibited growth of canine and human osteosarcoma cell lines, prompting the company to explore a possible in-vivo study in dogs with naturally occurring tumors.
Date: March 07 - March 07, 2019
Description:
The third part of this series of webinars focusing on neurological cases.
Event type: Webinar
Event Address:
Sponsor: Greyfriars https://www.greyfriarsrehab.co.uk
For More Information:





